@article{4a7a500842494855908364238265eedb,
title = "Cutaneous Adverse Events in Chronic Hepatitis C Patients Treated With New Direct-Acting Antivirals: A Systematic Review and Meta-Analysis.",
author = "Parth Patel and Kunal Malik and Karthik Krishnamurthy",
note = "Background: Direct-acting antivirals (DAAs) are known to present with additional dermatological events over pegylated-interferon/ribavirin (Peg-IFN/RBV). A systematic review and meta-analysis was conducted to assess the incidence/risk of cutaneous adverse events (AEs) for simeprevir, sofosbuvir, ABT450/r-ombitasvir, dasabuvir, ledipasvir, daclatasvir, and asunaprevir. The databases searched included PubMed, Clinicaltrials.gov, and Clinicaloptions.com.",
year = "2016",
month = jan,
day = "1",
doi = "10.1177/1203475415595775",
language = "American English",
volume = "20",
journal = "Journal of Cutaneous Medicine and Surgery",
number = "1",
}